[Asia Economy Reporter Oh Ju-yeon] Samil Pharmaceutical announced on the 31st that its operating profit on a consolidated basis turned to a profit of 4.7 billion KRW last year compared to the previous year. Sales increased by 28.0% to 121.1 billion KRW, and net profit also turned to a profit of 1.2 billion KRW.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing